reference/24763299

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24763299

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase III\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	1543
issn	0006-4971 1528-0020
issueIdentifier	5
pageRange	1538-1543
publicationName	Blood
startingPage	1538
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_266f09c09d1e3aa97cbfe9240f44f32b
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_34b8aef184ef3a6b42868615a951dc28 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_19c1d6e1282dcfe612268c0f9a05437d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8e1e289521a5a12717b28c0d6942253f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ae8eead882374ab5edc97c354dae218a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c4d7efc29b281ae219993d8e0fc0410b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_19ba57b8f4160071e772cff88662f7a0 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fa2d4b460d9a142e7e801597b7431edb http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_55098413e488fe549222e822982b903a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1b4dc9e318d9597323318f06aeaa39e5 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_40d27c83c72d589ef25cf90e9b3ddc29 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_121e0d8800c20575600fc0be879382e7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_388b3e975835df36b95f59c96b28ec42
bibliographicCitation	Kaplan LD, Lee JY, Ambinder RF, Sparano JA, Cesarman E, Chadburn A, Levine AM, Scadden DT. Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood. 2005 Sep 01;106(5):1538–43. PMID: 15914552; PMCID: PMC1895225.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_745ca2cde076927b410dc9a6f2b26736 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30fa652258ded15115c6eb3b78f621dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83dfd7db4cc074d83c855ca5c0880cca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d013a91f3e02c8be40fe5704a988048 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73b77b34d0b9cc4c7dc852b2f49b08d1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a03bc69f5cee18d0a36996459776aaee http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07f22c330173c96aa85e4780dd491ccd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb0b4ccf3157ed0c00bc835c3a0701d5
date	2005-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1182/blood-2005-04-1437 https://pubmed.ncbi.nlm.nih.gov/PMC1895225 https://pubmed.ncbi.nlm.nih.gov/15914552
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1243 https://portal.issn.org/resource/ISSN/0006-4971 https://portal.issn.org/resource/ISSN/1528-0020
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010
discusses	http://id.nlm.nih.gov/mesh/M0244307 http://id.nlm.nih.gov/mesh/M0544940 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0022676 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0006784
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008228Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D000911Q000008 http://id.nlm.nih.gov/mesh/D016483Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000069283 http://id.nlm.nih.gov/mesh/D014750Q000627 http://id.nlm.nih.gov/mesh/D004317Q000627 http://id.nlm.nih.gov/mesh/D011241Q000627 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D003520Q000627 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D006679 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D058846 http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6780 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7317 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f3366af2ce1555e259faab86aad3bef http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275

Total number of triples: 90.